Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.
Neurol Neuroimmunol Neuroinflamm
; 9(5)2022 09.
Article
in En
| MEDLINE
| ID: mdl-35701187
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
Neurol Neuroimmunol Neuroinflamm
Year:
2022
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States